Reneo Pharmaceuticals, Inc. (RPHM) Reports Q2 Loss of $0.16

Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) reported Q2 EPS of ($0.16), versus ($0.65) reported last year.

For earnings history and earnings-related data on Reneo Pharmaceuticals, Inc. (RPHM) click here.

You May Also Be Interested In

• Dell’s earning report was bullish for Intel CPU demand, analyst says
• StoneX on Mama’s Creations (MAMA): 'We Remain High-Conviction Buyers'
• StoneX Reiterates Hold Rating on Old Dominion Freight Line (ODFL) on QTD Operating Metrics